Press Releases | DEA.gov
Skip to main content
U.S. flag

An official website of the United States government

Here’s how you know

Dot gov

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Https

Secure .gov websites use HTTPS
A lock ( Lock A locked padlock ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

  • Who We Are
    • About
    • Mission
    • Leadership
    • History
    • Divisions
      • Domestic Divisions
      • Foreign Divisions
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • What We Do
    • Forensic Sciences
      • GUARDS
      • Forensic Sciences Policy
      • Forensic Science Organizations
      • Forensic Science Contact
    • Law Enforcement
      • DEA Office of Training
        • Office of Training Programs
      • El Paso Intelligence Center (EPIC)
      • Intelligence
      • Operations
        • Administrative Law Judges
        • DEA Asset Forfeiture
        • Domestic Cannabis Suppression / Eradication Program
        • HIDTA
        • OCDETF
    • Education and Prevention
      • Family Summit
      • Red Ribbon
      • Kiki and the History of Red Ribbon Week
      • Red Ribbon Toolkit - Resources For Your Community
      • DEA’s Family Summit
      • Operation Engage
      • Community Outreach
      • Just Think Twice
      • Campus Drug Prevention
      • Get Smart About Drugs
      • Operation Prevention
    • Drug Information
      • Drug Policy
      • Drug Scheduling
      • The Controlled Substances Act
    • News
      • Alerts
      • Press Releases
      • Most Wanted Fugitives
        • All Fugitives
      • Stories
      • Events
      • Speeches
      • Testimony
    • Campaigns
      • One Pill Can Kill
        • Senior Citizens
        • Partner Toolbox
        • Social Media Campaign
      • DEA National Prescription Drug Take Back Day
  • Careers
    • Special Agent
      • Special Agent FAQs
    • Diversion Investigator
      • Diversion Investigator Job Announcement
    • Intelligence Research Specialist
      • Intelligence Research Specialist Job Announcements
      • Intelligence Research Specialists FAQs
      • Schedule A Hiring Authority: Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
      • How To Claim Veterans' Preference
      • Priority Consideration
      • Benefits
      • Veterans and People With Disabilities
      • Operation Warfighter
  • Resources
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
      • Domestic Arrests
      • Staffing and Budget
    • FOIA
      • About FOIA
      • Contact DEA FOIA
      • Make a Request
      • What Happens After Making a Request
      • Requester Categories
      • Fees Charged
      • Fee Waiver
      • FOIA FAQ
      • FOIA Logs and Reports
      • FOIA Library
      • Additional FOIA Links
      • FOIA Exemptions
      • What Are Exclusions?
      • Privacy Act
      • Privacy Act Exemptions
      • Privacy Impact Assessment and Management Information Systems
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
      • Victim Witness Assistance Program Resources
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Get Updates
  • Scam Alert
  • Full Menu
  • English
  • Español

Main Menu

Explore DEA
  • Who We Are
    • About
    • Mission
    • Leadership
    • History
    • Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Education and Prevention
    • Drug Information
    • News
    • Campaigns
  • Careers
    • Special Agent
    • Diversion Investigator
    • Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
  • Resources
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
    • FOIA
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
  • Submit A Tip

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2025 (52)
  • 2024 (45)
  • 2023 (77)
  • 2022 (86)
  • 2021 (77)
  • 2020 (18)
  • 2019 (25)
  • 2018 (6)
  • 2017 (4)
  • 2003 (1)

Subject

  • Drug Trafficking (4010)
  • Synthetic drugs (1064)
  • Guns/Weapons (989)
  • OCDETF/Task Force (810)
  • Fake Pills (654)
  • Arrests/Convictions - Major (603)
  • Guilty Plea (529)
  • Seizures (Drugs/Property) (456)
  • Overdose (321)
  • Major Law Enforcement Operation (267)
  • Take Back Day (246)
  • Diversion Division (242)
  • Task Forces/Task Force Officers (230)
  • Pharmaceuticals/Pharmacists/Physicians (224)
  • Money Laundering (203)
  • Gangs (196)
  • Outreach/Drug Prevention (184)
  • Fentanyl Awareness (152)
  • One Pill Can Kill (110)
  • HIDTA (103)
  • Press Conferences (68)
  • Narcoterrorism (53)
  • Prevention/Education - DEA websites GSAD, JTT etc (53)
  • Extraditions (50)
  • Public and Media Affairs - also see Congressional Affairs (50)
  • Dark Web- Internet Trafficking (29)
  • Asset Forfeiture (28)
  • International/Foreign Operations (28)
  • Congressional Affairs (15)
  • Terrorism (14)
  • Fentanyl Free America (12)
  • Intergovernmental Affairs (9)
  • Other (8)
  • Campaigns (7)
  • Critical Incident (6)
  • Counterfeit Pills (5)
  • Intelligence Division - Intelligence Products (5)
  • Scam Calls (5)
  • Museum and Visitors Center (3)
  • El Paso Intelligence Center (2)
  • Recruitment/Office of Training/Graduations (2)
  • Prescription Drugs (364)
  • Red Ribbon (27)

Drug Name

  • Oxycodone (75)
  • Opioids (57)
  • Fentanyl (53)
  • Synthetic Opioids (21)
  • Hydromorphone (18)
  • Benzodiazepines (13)
  • Methamphetamine (13)
  • Morphine (10)
  • Amphetamines (9)
  • Cocaine (8)
  • Heroin (6)
  • Methadone (5)
  • Marijuana (Cannabis) (3)
  • Steroids (3)
  • Ketamine (2)
  • GHB (1)
  • Marijuana Concentrates (1)
  • Psilocybin (1)

Field Division

  • Washington, DC (45)
  • St. Louis (39)
  • New York (34)
  • Headquarters (30)
  • New England (25)
  • Seattle (23)
  • Omaha (21)
  • Atlanta (19)
  • Miami (18)
  • Chicago (17)
  • Dallas (15)
  • New Jersey (15)
  • El Paso (14)
  • Houston (12)
  • San Francisco (12)
  • Louisville (11)
  • Los Angeles (9)
  • New Orleans (8)
  • San Diego (7)
  • Phoenix (6)
  • Rocky Mountain (6)
  • Detroit (3)
  • Philadelphia (1)
Clear All Results
PRESS RELEASE

Pill Mill Operator Convicted for Oxycodone Diversion

September 08, 2022
NEW YORK - Damian Williams, the United States Attorney for the Southern District of New York, announced that a jury returned a guilty verdict yesterday against Purificacion Cristobal for her participation in a conspiracy to distribute oxycodone without a legitimate medical purpose acting outside the usual course of professional practice...
September 08, 2022
PRESS RELEASE

Osteopathic Physician Sentenced for Illegally Prescribing Drug

September 07, 2022
ST. LOUIS – U.S. District Judge Ronnie L. White on Wednesday sentenced an osteopathic physician from Collinsville, Illinois, to a year in prison for illegally prescribing an anti-anxiety drug. Matthew Steven Miller, 43, wrote prescriptions for the anti-anxiety drug Xanax for six people who were not his patients between 2016...
September 07, 2022
PRESS RELEASE

New Jersey Pharmacy Admits Illegal Distribution of Prescription Opioids and Kickback Scheme

August 03, 2022
NEWARK, N.J. – Susan A. Gibson, Special Agent in Charge of the Drug Enforcement Administration’s New Jersey Division, Scott J. Lampert, Special Agent in Charge of the U.S. Department of Health and Human Services, Office of Inspector General, Office of Investigations-New Jersey Field Office, Patrick J. Hegarty, Defense Criminal Investigative...
August 03, 2022
PRESS RELEASE

Justice Department Obtains Temporary Restraining Order to Prevent Tampa-Area Physician from Writing Opioid Prescriptions

July 29, 2022
WASHINGTON – A federal court issued a temporary restraining order prohibiting a Tampa-area physician from prescribing opioids and other controlled substances, the Department of Justice announced today. In a complaint filed on July 18, and unsealed yesterday, the United States alleges that Dr. Neelam Taneja Uppal unlawfully wrote opioid prescriptions...
July 29, 2022
PRESS RELEASE

Federal Court Orders Clinic to Close, Physician and Clinic Owners to Pay $600,000 for Alleged Unlawful Opioid Distribution

July 27, 2022
WASHINGTON – A federal court ordered a Tampa-area pain management clinic to close and directed the clinic’s owners and its former physician to collectively pay $600,000 in civil penalties pursuant to agreed resolutions in a case alleging violations of the Controlled Substances Act (CSA), the Justice Department announced today. In...
July 27, 2022
PRESS RELEASE

Minnesota Pharmacist Pleads Guilty to Misappropriating and Adulterating Prescription Pain Medication

July 20, 2022
MINNEAPOLIS – A Minneapolis woman has pleaded guilty to misappropriating and adulterating prescription morphine while working as a pharmacist. According to court documents, on October 30, 2019, Jennifer Lee Draheim, 42, a pharmacist at Coburn’s Pharmacy in Ramsey, removed a bottle of morphine sulfate from the Scheduled Drug Cabinet and...
July 20, 2022
PRESS RELEASE

East Windsor Man Admits Role In Oxycodone Prescription Fraud Scheme

July 19, 2022
EAST WINDSOR, Conn. - Vanessa Roberts Avery, United States Attorney for the District of Connecticut, today announced that an East Windsor man has admitted his role in a scheme to acquire and distribute oxycodone obtained through fraudulent prescriptions. On July 5, 2022, JAYSON KEMP, 45, pleaded guilty before U.S. District...
July 19, 2022
PRESS RELEASE

Oklahoma City Hospital Pays $120,000 to Settle Civil Penalty Claims

July 19, 2022
OKLAHOMA CITY, OK – INTEGRIS ProHealth, Inc., and its parent, INTEGRIS Health, Inc. (collectively, “INTEGRIS”) paid $120,000 to settle civil penalty claims stemming from allegations that Integris Baptist Medical Center Pharmacy (“Integris Pharmacy”), which is owned and operated by INTEGRIS ProHealth, Inc., violated the Comprehensive Drug Abuse Prevention and Control...
July 19, 2022
PRESS RELEASE

Former Oregon Dentist Pleads Guilty in Federal Drug Case

July 13, 2022
PORTLAND, Ore.—A former Clackamas, Oregon dentist pleaded guilty today to illegally distributing controlled substances, including prescription drugs, and anabolic steroids. Salwan Wesam Adjaj, 43, a resident of West Linn, Oregon, waived indictment and pleaded guilty to a one-count information charging him with distributing and possessing with intent to distribute controlled...
July 13, 2022
PRESS RELEASE

New Mexico Pharmacy Agrees to Settlement Relating to Violations of the Controlled Substances Act

July 12, 2022
ALBUQUERQUE, N.M. – Alexander M.M. Uballez, United States Attorney for the District of New Mexico, announced today that Joe’s Pharmacy of Peralta, New Mexico, has agreed to pay to the United States $50,000 representing civil penalties under the Controlled Substances Act (CSA). The agreement settles civil claims against Joe’s Pharmacy...
July 12, 2022
Showing 201 - 210 of 391 results

Pagination

  • First page «
  • Previous page ‹
  • Page 17
  • Page 18
  • Page 19
  • Page 20
  • Current page 21
  • Page 22
  • Page 23
  • Page 24
  • Page 25
  • Next page ›
  • Last page »
  • Who We Are
    • About
    • Domestic Divisions
    • Foreign Offices
    • Contact Us
    • DEA Museum
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Drug Prevention
    • Diversion Control Division
    • News
  • Careers
    • Special Agent
    • Diversion Investigator
    • Forensic Sciences
    • Intelligence Research Specialist
    • How to Apply
  • Resources
    • Drug Information
    • Employee Assistance Program
    • FOIA
    • Publications
    • Media Galleries
    • VWAP
  • Doing Business
    with the DEA
    • Overview
    • Current Vendors
    • Prospective Vendors
    • Security Clauses
    • Security Forms
    • Small Business Program
    • Vendor Engagement Request
  • Policies
    • Accessibility & Policy
    • Legal Policies & Disclaimers
    • No FEAR Act
    • Privacy Policy
    • U.S. Department of Justice EEO Policy
    • USA.gov
    • Whistleblower Protection
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000 info@dea.gov
Contact the Webmaster